Lehfilcon A toric contact lenses
DeviceCommercially available soft contact lenses worn as indicated
Other names: TOTAL30™ for Astigmatism, T30fA
NCT Number: NCT06165627
The purpose of this study is to assess the clinical performance of TOTAL30 for Astigmatism (T30fA) soft contact lenses with Biofinity Toric soft contact lenses.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
Kurata Eye Care Center, Los Angeles, California, United States
Subjects will be expected to attend 5 office visits and will be dispensed study lenses (per randomization sequence) for 30-day duration of bilateral wear with each study lens (approximately 60 days of lens wear). The total duration of the subject's participation in the study will be approximately 74 days.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Key Inclusion Criteria:
Key Exclusion Criteria:
Commercially available soft contact lenses worn as indicated
Other names: TOTAL30™ for Astigmatism, T30fA
Commercially available soft contact lenses) worn as indicated
Other names: Biofinity® Toric, Biofinity Toric
Commercially available hydrogen peroxide-based solution for daily cleaning and disinfection of contact lenses used as indicated
Other names: CLEAR CARE® Cleaning & Disinfecting Solution
Time frame: Day 30 of each wear period. A wear period was 30 days [-1/+3 days] according to randomization assignment.
Visual Acuity (VA) was assessed for each eye individually with study lenses in place while reading letter charts. VA was recorded in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen VA (normal distance eyesight), with lower logMAR values representing better eyesight.
Alcon Research
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05959200
Ametropia, Astigmatism
Oakland, California, United States
View Trial DetailsNCT05483127
Ametropia, Astigmatism
Los Angeles, California, United States
View Trial DetailsNCT03688672
Ametropia, Astigmatism
Columbus, Ohio, United States
View Trial DetailsNCT04908488
Ametropia, Astigmatism
Los Angeles, California, United States
View Trial Details